{
  "Symbol": "WST",
  "AssetType": "Common Stock",
  "Name": "West Pharmaceutical Services Inc",
  "Description": "West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.",
  "CIK": "105770",
  "Exchange": "NYSE",
  "Currency": "USD",
  "Country": "USA",
  "Sector": "MANUFACTURING",
  "Industry": "FABRICATED RUBBER PRODUCTS, NEC",
  "Address": "530 HERMAN O. WEST DRIVE, EXTON, PA, US",
  "OfficialSite": "https://www.westpharma.com",
  "FiscalYearEnd": "December",
  "LatestQuarter": "2024-12-31",
  "MarketCapitalization": "14883622000",
  "EBITDA": "749000000",
  "PERatio": "30.77",
  "PEGRatio": "3.449",
  "BookValue": "37.1",
  "DividendPerShare": "0.81",
  "DividendYield": "0.0041",
  "EPS": "6.69",
  "RevenuePerShareTTM": "39.63",
  "ProfitMargin": "0.17",
  "OperatingMarginTTM": "0.229",
  "ReturnOnAssetsTTM": "0.0993",
  "ReturnOnEquityTTM": "0.177",
  "RevenueTTM": "2893200000",
  "GrossProfitTTM": "998500000",
  "DilutedEPSTTM": "6.69",
  "QuarterlyEarningsGrowthYOY": "-0.021",
  "QuarterlyRevenueGrowthYOY": "0.023",
  "AnalystTargetPrice": "284.51",
  "AnalystRatingStrongBuy": "2",
  "AnalystRatingBuy": "8",
  "AnalystRatingHold": "2",
  "AnalystRatingSell": "0",
  "AnalystRatingStrongSell": "0",
  "TrailingPE": "30.77",
  "ForwardPE": "33.78",
  "PriceToSalesRatioTTM": "5.14",
  "PriceToBookRatio": "5.55",
  "EVToRevenue": "5.08",
  "EVToEBITDA": "19.76",
  "Beta": "1.22",
  "52WeekHigh": "393.65",
  "52WeekLow": "187.43",
  "50DayMovingAverage": "227.11",
  "200DayMovingAverage": "292.73",
  "SharesOutstanding": "72293000",
  "DividendDate": "2025-05-07",
  "ExDividendDate": "2025-04-30",
  "Last Updated": "2025-04-23 14:46:06",
  "Price_Day_1": 215.13,
  "Price_Day_2": 205.88,
  "Price_Day_3": 201.9,
  "Price_Day_4": 209.13,
  "Price_Day_5": 212.5,
  "Price_Day_6": 212.67,
  "Price_Day_7": 210.7,
  "Income_totalRevenue_Q1": "748800000",
  "Income_grossProfit_Q1": "273600000",
  "Income_netIncome_Q1": "130100000",
  "Income_totalRevenue_Q2": "746900000",
  "Income_grossProfit_Q2": "264700000",
  "Income_netIncome_Q2": "136000000",
  "Income_totalRevenue_Q3": "702000000",
  "Income_grossProfit_Q3": "231300000",
  "Income_netIncome_Q3": "111300000",
  "Income_totalRevenue_Q4": "695400000",
  "Income_grossProfit_Q4": "230200000",
  "Income_netIncome_Q4": "115300000",
  "Balance_totalAssets_Q1": "3643400000",
  "Balance_totalLiabilities_Q1": "961100000",
  "Balance_totalShareholderEquity_Q1": "2682300000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q1": "484600000",
  "Balance_totalAssets_Q2": "3675100000",
  "Balance_totalLiabilities_Q2": "923000000",
  "Balance_totalShareholderEquity_Q2": "2752100000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q2": "490900000",
  "Balance_totalAssets_Q3": "3489400000",
  "Balance_totalLiabilities_Q3": "912600000",
  "Balance_totalShareholderEquity_Q3": "2576800000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q3": "446200000",
  "Balance_totalAssets_Q4": "3602300000",
  "Balance_totalLiabilities_Q4": "921700000",
  "Balance_totalShareholderEquity_Q4": "2680600000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q4": "601800000",
  "Debt to Equity Ratio": 0.36,
  "Is Complete": true
}